SCHEMBL17630089

SCHEMBL17630089

N#Cc1ccc(I)c(CCc2ccncc2)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.41
CYP11B2 P19099 3/20 0.41
CYP19A1 P11511 2/20 0.41
CHUK O15111 1/20 0.37
PKN1 Q16512 1/20 0.35
PKN2 Q16513 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
ABCB1 P08183 2/20 0.34
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
NAAA Q02083 1/20 0.33
ROCK2 O75116 1/20 0.33
DAO P14920 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
GSK3A P49840 2/20 0.33
GSK3B P49841 2/20 0.33
NAMPT P43490 1/20 0.33
TTK P33981 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17629898 0.82 CYP11B2 (0.44) CYP11B1CYP11B2CYP19A1
SCHEMBL17630001 0.81 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1CHUKPKN1
SCHEMBL17672507 0.80 CYP19A1 (0.41) CYP11B1CYP11B2CYP19A1
SCHEMBL31483664 0.75 MEN1 (0.43) CYP19A1
SCHEMBL17643416 0.75 MEN1 (0.43) CYP19A1
SCHEMBL17629989 0.75 ADRA2C (0.47) LOXL2
SCHEMBL17672592 0.75 LMNA (0.46) ABCB1CCNCCDK8NAAAABCG2
SCHEMBL17630107 0.75 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1PKN1PKN2
SCHEMBL17672718 0.74 LRRK2 (0.36) CDK8
SCHEMBL17679257 0.74 HRH1 (0.48) CYP11B1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055947-A1 ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-04-14 WO disclosed
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed